Diabetes and Psoriasis
May 21, 2022 updated by: Giuseppe Derosa, University of Pavia
Diabetes and Psoriasis: Study on Prevalence, Role of Inflammation and Insulin-resistance
Patients with psoriasis will be evaluated.
The investigators will collect personal history, concomitant diseases and in particular the presence of type 2 diabetes mellitus, impaired fasting glucose and impaired glucose tollerance.
The aim of the study will be to evaluate if there is a correlation among inflammation, insulin-resistance and psoriasis.
Study Overview
Study Type
Observational
Enrollment (Actual)
425
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Pavia, Italy, 27100
- irccs policlinico san matteo foundation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with psoriasis
Description
Inclusion Criteria:
- patients with psoriasis
Exclusion Criteria:
- NA
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evaluation of correlation between diabetes and psoriasis
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Giuseppe Derosa, MD, PhD, FESC, University of Pavia - IRCCS Policlinico San Matteo Foundation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2015
Primary Completion (Actual)
February 28, 2018
Study Completion (Actual)
June 30, 2018
Study Registration Dates
First Submitted
February 11, 2015
First Submitted That Met QC Criteria
February 11, 2015
First Posted (Estimate)
February 19, 2015
Study Record Updates
Last Update Posted (Actual)
May 24, 2022
Last Update Submitted That Met QC Criteria
May 21, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P-20140023881
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.